Tag Archives: ISP

Hot High Tech Stocks To Invest In Right Now

Tutor Perini (NYSE:TPC) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report released on Wednesday.

According to Zacks, “Tutor Perini Corporation provides diversified general contracting, construction management and design-build services to private clients and public agencies worldwide. The company operates in four segments: Civil, Building, Specialty Contractors, and Management Services. The Civil segment engages in public works construction activities and the repair, replacement, and reconstruction of infrastructure. The Building segment offers services in specialized building markets, including hospitality and gaming, transportation, healthcare, municipal offices, sports and entertainment, education, correctional facilities, biotech, pharmaceutical, industrial, and high technology. The Specialty Contractors segment provides plumbing, HVAC, electrical, mechanical, and concrete services for the industrial, commercial, hospitality and gaming, and transportation markets. The Management Services segment offers construction and design-build services to the U.S. military and government agencies, and multi-national corporations. “

Hot High Tech Stocks To Invest In Right Now: Gevo, Inc.(GEVO)

Gevo, Inc. (Gevo), incorporated on June 9, 2005, is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo, Inc. segment also develops, maintains and protects its intellectual property portfolio, develops future markets for its isobutanol and provides corporate oversight services. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.

The Company has developed the Gevo Integrated Fermentation Technology (GIFT), an integrated technology platform for the production and separation of renewable isobutanol in order to produce and sell isobutanol made from renewable sources. GIFT consists of two components: biocatalysts that convert sugars derived from multiple renewable feed stocks into isobutanol through fermentation and a separation unit that is designed to continuously separate isobutanol during the fermentation process. GIFT is designed to permit the retrofit of existing ethanol capacity to produce isobutanol, ethanol or both products simultaneously or the addition of renewable isobutanol or ethanol production capabilities to a facility’s existing ethanol production by adding additional fermentation capacity side-by-side with the facility’s existing ethanol fermentation capacity (collectively refer! red to as Retrofit). Just like ethanol production, after fermentation, a primary product (isobutanol) and a co-product (iDGs) are recovered for sale. The main modifications of the GIFT system are replacing the ethanol producing yeast with Gevo’s isobutanol producing biocatalyst, and adding low temperature distillation equipment for continuous removal and separation of isobutanol. The Company has also developed new technologies using ethanol as a feedstock for the production of hydrocarbons, renewable hydrogen, and other chemical intermediates, which it describes as its ethanol-to-olefins (ETO) technologies. The process produces tailored mixes of isobutylene, propylene, hydrogen and acetone, which are used as standalone molecules, or as feedstocks to produce other chemical products and longer chain alcohols. At this time, this technology has only been operated at a laboratory scale.

The Company competes with Butamax Advanced Biofuels LLC, Cathay Industrial Biotech Ltd., METabolic EXplorer S.A., Eastman Chemicals Company, Green Biologics Ltd., Shell Oil Company, DuPont-Danisco Cellulosic Ethanol LLC, Abengoa Bioenergy, S.A., POET, LLC, ICM, Mascoma Corporation, Inbicon A/S, INEOS New Planet BioEnergy LLC, Coskata, Inc., Archer Daniels Midland Company, BlueFire Ethanol, Inc., IncZeaChem Inc., ZeaChem Inc., Iogen Corporation, Qteros, Inc., Global Bioenergies, S.A., Virent Energy Systems, Inc., Renewable Energy Group, Inc., Amyris Biotechnologies, Inc. and Valero Energy Corporation.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Gevo Inc (NASDAQ:GEVO) traded down 5.9% on Thursday . The company traded as low as $4.12 and last traded at $4.29. 529,018 shares changed hands during mid-day trading, a decline of 36% from the average session volume of 832,918 shares. The stock had previously closed at $4.56.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Gevo (GEVO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot High Tech Stocks To Invest In Right Now: Vascular Biogenics Ltd.(VBLT)

Vascular Biogenics Ltd., incorporated on January 31, 2000, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Company’s program is based on its Vascular Targeting System (VTS) platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. Its lead product candidate, VB-111(ofranergene obadenovec), is a gene-based biologic that it is developing for solid tumor indications, with a program for recurrent glioblastoma (rGBM), a form of brain cancer. It also is engaged in conducting a program focusing anti-inflammatory diseases, based on the use of its Lecinoxoid platform technology. Lecinoxoids are a class of small molecules it developed that are structurally and functionally similar to naturally occurring molecules known to modulate inflammation. The lead product candidate from this program, VB-201, is a Phase II-ready molecule that demonstrated efficacy in reducing vascular inflammation in a Phase II sub-study in psoriatic patients with cardiovascular risk.

VTS Platform

The Company’s VTS platform technology enables systemic administration of gene therapy to either destroy or promote angiogenic blood vessels. VTS is both tissue- and condition-specific, allowing for targeted and limited gene expression in endothelial cells, the thin layer of cells that lines the interior surface of blood vessels undergoing angiogenesis. Its VTS platform technology comprises three components: a viral vector, a promoter and a transgene. The viral vector is a modified virus that is used as a delivery vehicle to distribute the promoter and the transgene throughout the body. The promoter is its genetically modified promoter, PPE-1-3X, which specifically targets the endothelial cells of angiogenic blood vessels. The transgene is a genetic sequence designed to yield a specific biologic effect, the expression of which is directed by PPE-1-3X.

The Company has studied VB-111 in a Phase I all comers trial involving patients with multiple types of metastatic cancer types, including thyroid cancer, neuroendocrine cancer, renal cell carcinoma and lung cancer. In that trial, VB-111 was tolerated and showed a dose- dependent extension in median overall survival across a range of tumor types. Its VTS platform technology enables systemic administration of gene therapy to either destroy or promote angiogenic blood vessels. It has also generated additional product candidates, which utilize the same vector and promoter as in VB-111, and comprise alternative functional transgenes, which include VB-511, an anti-angiogenic candidate; VB-211 and VB-411, which are pro-angiogenic candidates that may be employed for ischemic conditions, such as peripheral vascular disease.

Lecinoxoid Platform

The Company’s Lecinoxoid platform technology comprises a family of orally administered small molecules designed to modulate the body’s inflammatory response. Lecinoxoids are compounds that are structurally and functionally similar to naturally occurring molecules, known as oxidized phospholipids, which possess immune modulating anti-inflammatory properties, modified to manage stability and activity. Its lead Lecinoxoid-based compound, VB-201, is designed as an oral agent for the control of chronic inflammatory disorders. VB-201 inhibits the CD-14/TLR4 and TLR2 pathways, as well as monocyte migration. The Company has also developed second and third generations of Lecinoxoid product candidates.

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading.
    ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday.
    Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent.
    Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday.
    Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter.
    Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday.
    Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading.
    Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss.
    Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook.
    ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering

  • [By Lisa Levin] Companies Reporting Before The Bell
    Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion.
    J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion.
    Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion.
    The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million.
    Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million.
    Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million.
    KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million.
    Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share.
    Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million.
    Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.

     

Hot High Tech Stocks To Invest In Right Now: PacWest Bancorp(PACW)

PacWest Bancorp, incorporated on March 24, 2008, is a bank holding company for Pacific Western Bank (the Bank). The Company is focused on relationship-based business banking to small, middle-market and venture-backed businesses. The Bank offers a range of loan and deposit products and services through approximately 80 branches located throughout the state of California. The Company provides commercial banking services, and deposit and treasury management services to small and middle-market businesses. It offers products and services under the brand names of Pacific Western, as well as its business groups, CapitalSource Inc. and Square 1 Bank. CapitalSource focuses on providing cash flow, asset-based, equipment and real estate loans and treasury management services to middle market businesses. Square 1 Bank focuses on providing a range of financial products to service entrepreneurial businesses and their venture capital and private equity investors. Square 1 Asset Management, Inc., a subsidiary of the Bank, provides investment advisory and asset management services.

Lending Activities

The Company conducts a range of commercial lending activities that includes real estate mortgage, real estate construction and land loans, and commercial and industrial (C&I) loans and leases. Its commercial real estate loans are secured by a range of property types. Its C&I loan offerings are diverse and include various asset-secured loans, equipment-secured loans and leases, cash flow loans (leveraged loans) to finance business acquisitions and recapitalizations, and venture loans to support the operations of entrepreneurial companies during the various phases of their start-up operations. Its C&I loans include cash flow loans, asset-based loans, equipment-secured loans and leases, and venture capital loans. Its real estate lending activities focuses on loans to professional developers and real estate investors for the acquisition, refinancing and construction of commercial real estate. Its con! sumer loans include personal loans, auto loans, home equity lines of credit, revolving lines of credit, other loans made by banks to individual borrowers, and purchased participation interests in student loans originated and serviced by a third-party lender. The Company’s total loans are approximately $14.48 billion.

Investment Activities

The Company’s investment securities are classified as securities available-for-sale. The Company’s investment portfolio consists of obligations of states and political subdivisions (municipal securities), the United States Government agency obligations, and government-sponsored enterprise (GSE) obligations. The Company owns approximately $3.6 billion of investment securities available-for-sale.

Sources of Funds

The Company’s main source of funds to support its revenue-generating assets and to provide a source of low-cost funds and deposit-related fee income are deposits. The Company offers deposit products to businesses and other customers with a range of rates and terms, including demand, money market and time deposits. It also provides international banking services, multi-state deposit services, asset management services, as well as product offerings through other correspondent banks. The Company’s total deposits consist of approximately $10.6 billion in core deposits, approximately $4.2 billion in time deposits and over $0.9 billion in brokered non-maturity deposits. The Company borrows funds on a long-term, short-term or overnight basis from the Federal Home Loan Banks (FHLB), the Federal Reserve Bank of San Francisco (FRBSF) or other financial institutions.

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine upgraded shares of PacWest Bancorp (NASDAQ:PACW) from a sell rating to a hold rating in a research report report published on Wednesday morning.

  • [By Ethan Ryder]

    PacWest Bancorp (NASDAQ:PACW) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    PagSeguro Digital (NYSE:PAGS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Shane Hupp]

    PacWest Bancorp (NASDAQ:PACW) – Stock analysts at Wedbush reduced their Q1 2019 earnings per share estimates for shares of PacWest Bancorp in a research report issued on Wednesday, September 12th. Wedbush analyst D. Chiaverini now forecasts that the financial services provider will earn $0.89 per share for the quarter, down from their prior estimate of $0.90. Wedbush currently has a “Neutral” rating on the stock. Wedbush also issued estimates for PacWest Bancorp’s Q1 2020 earnings at $0.98 EPS and Q2 2020 earnings at $1.02 EPS.

Hot High Tech Stocks To Invest In Right Now: CPS Technologies Corp.(CPSH)

CPS Technologies Corporation produces and sells advanced material solutions to the transportation, automotive, energy, computing/Internet, telecommunication, aerospace, defense, and oil and gas markets. Its products are used in applications that involve energy use or energy generation. The company primarily offers metal matrix composites that are a combination of metal and ceramic, such as baseplates for various applications, including motor controllers used in electric trains, subway cars, wind turbines, and hybrid and electric vehicles; baseplates and housings for use in radar, satellite, and avionics applications, as well as in modules built with wide band gap semiconductors; and lids and heatspreaders used with integrated circuits for use in Internet switches and routers. It also assembles housings and packages for hybrid circuits. CPS Technologies Corporation primarily sells its products to microelectronics systems houses in the United States, Europe, and Asia. The company was formerly known as Ceramics Process Systems Corporation and changed its name to CPS Technologies Corporation in March 2007. CPS Technologies Corporation was incorporated in 1984 and is headquartered in Norton, Massachusetts.

Advisors’ Opinion:

  • [By Max Byerly]

    Media coverage about CPS Technologies (NASDAQ:CPSH) has been trending somewhat negative recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CPS Technologies earned a media sentiment score of -0.04 on Accern’s scale. Accern also gave news headlines about the electronics maker an impact score of 47.6937573591172 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Hot High Tech Stocks To Invest In Right Now: ING Group, N.V.(ISP)

ING Groep N.V. (ING) is a financial institution. The Company offers banking services. The Company’s segments include Retail Netherlands, which offers current and savings accounts, business lending, mortgages and other consumer lending in the Netherlands; Retail Belgium, which offers products are similar to those in the Netherlands; Retail Germany, which offers current and savings accounts, mortgages and other customer lending; Retail Other, which offers products are similar to those in the Netherlands, and Wholesale Banking, which offers wholesale banking activities (a full range of products from cash management to corporate finance), real estate and lease. The Company’s Retail Banking business lines provide products and services to individuals, small and medium-sized enterprises (SMEs) and mid-corporates. ING Bank’s subsidiary in the United States is ING Financial Holdings Corporation. Advisors’ Opinion:

  • [By Logan Wallace]

    Berenberg Bank set a €2.20 ($2.56) price target on Intesa Sanpaolo (BIT:ISP) in a research report sent to investors on Wednesday. The brokerage currently has a neutral rating on the stock.

  • [By Ethan Ryder]

    Intesa Sanpaolo (BIT:ISP) has been given a €2.15 ($2.50) target price by stock analysts at UBS Group in a research note issued on Tuesday, www.boersen-zeitung.de reports. The firm presently has a “neutral” rating on the stock.

  • [By Stephan Byrd]

    Intesa Sanpaolo (BIT:ISP) received a €2.90 ($3.37) price target from research analysts at Deutsche Bank in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the stock.

  • [By Logan Wallace]

    Jefferies Financial Group set a €2.05 ($2.38) target price on Intesa Sanpaolo (BIT:ISP) in a report published on Tuesday. The brokerage currently has a neutral rating on the stock.

Hot High Tech Stocks To Invest In Right Now: DraftKings Inc.(DKNG)

DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States. It operates through two segments, Business-to-Consumer and Business-to-Business. The company provides users with daily sports, sports betting, and iGaming opportunities. It is also involved in the design, development, and licensing of sports betting and casino gaming platform software for online and retail sportsbook, and casino gaming products. The company distributes its product offerings through various channels, including traditional websites and direct app downloads, as well as direct-to-consumer digital platforms, such as the Apple App store and the Google Play store. DraftKings Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.

Advisors’ Opinion:

  • [By Thomas Niel]

    Like other “meme stocks,” a lot of the appeal with FUBO stock is its chance of getting short-squeezed. Short interest runs high (currently 17.5% of float), as bears are betting big that the company’s sports streaming/wagering platform will fail to find success due to high competition from big media, as well as from early-movers in the online sportsbook space such as DraftKings (NASDAQ:DKNG).

  • [By Dana Blankenhorn]

    If there’s a stock perfect for the “Bro Investor” who likes risk, action, and (potentially) a big pay-off, it’s DraftKings (NASDAQ:DKNG).

Hot Value Stocks For 2019

Emotions and psychological influences obviously affect decision-making. Fear, confidence levels, anger and greed are just a few of the very human factors that play a role in not only how individual investment portfolios fare but in how entire markets perform.

Ideally, the decisions made by investors are entirely objective and data-driven. That is rarely the case, however. People are incapable of escaping themselves. Benjamin Graham, the “father of value investing” and author of the seminal works “Security Analysis and the Intelligent Investor,” famously declared in the latter (published way back in 1949, mind you) that “the investor’s chief problem — and even his worst enemy — is likely to be himself.”

mapodile | E+ | Getty Images

The mental roadblocks humans tend to throw in front of their efforts to make sound decisions have come to be known as “cognitive biases.” Cognitive biases are so apparent and so inherent that there’s no disputing their existence.

Hot Value Stocks For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Berenberg Bank set a €2.20 ($2.56) price target on Intesa Sanpaolo (BIT:ISP) in a research report sent to investors on Wednesday. The brokerage currently has a neutral rating on the stock.

  • [By Logan Wallace]

    Jefferies Financial Group set a €2.05 ($2.38) target price on Intesa Sanpaolo (BIT:ISP) in a report published on Tuesday. The brokerage currently has a neutral rating on the stock.

  • [By Stephan Byrd]

    Intesa Sanpaolo (BIT:ISP) received a €2.90 ($3.37) price target from research analysts at Deutsche Bank in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the stock.

Hot Value Stocks For 2019: Autohome Inc.(ATHM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Raymond James & Associates reduced its stake in shares of Autohome Inc (NYSE:ATHM) by 3.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 229,347 shares of the information services provider’s stock after selling 7,721 shares during the quarter. Raymond James & Associates owned 0.19% of Autohome worth $23,164,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

    Get Autohome alerts:

    Dow Jones Falls Before Trump’s Iran Decision; These 2 IBD 50 Stocks Jump (investors.com) Autohome Quarterly Earnings Beat Estimates, Guides Higher (finance.yahoo.com) Autohome (ATHM) Posts Earnings Results, Beats Expectations By $0.11 EPS (americanbankingnews.com) Earnings Reaction History: Autohome Inc., 44.4% Follow-Through Indicator, 4.6% Sensitive (nasdaq.com) BRIEF-Autohome Reports Qtrly Earnings Per Share Of RMB 4.05 (reuters.com)

    Several analysts have recently commented on the stock. ValuEngine raised shares of Autohome from a “hold” rating to a “buy” rating in a research report on Wednesday, April 11th. Zacks Investment Research raised shares of Autohome from a “hold” rating to a “buy” rating and set a $99.00 price objective for the company in a research report on Monday, March 12th. One analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $73.97.

  • [By Logan Wallace]

    Autohome (NYSE:ATHM) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Wednesday.

  • [By Motley Fool Transcribers]

    Autohome Inc  (NYSE:ATHM)Q4 2018 Earnings Conference CallFeb. 26, 2019, 7:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Hot Value Stocks For 2019: Seanergy Maritime Holdings Corp(SHIP)

Advisors’ Opinion:

  • [By Logan Wallace]

    ShipChain (CURRENCY:SHIP) traded 6.6% higher against the dollar during the 1-day period ending at 23:00 PM Eastern on September 4th. ShipChain has a total market capitalization of $4.08 million and $3,218.00 worth of ShipChain was traded on exchanges in the last day. In the last week, ShipChain has traded up 5.8% against the dollar. One ShipChain token can currently be bought for $0.0203 or 0.00000276 BTC on popular cryptocurrency exchanges including HitBTC and IDEX.

  • [By Max Byerly]

    Ship Finance International (NYSE:SFL) and Seanergy Maritime (NASDAQ:SHIP) are both small-cap transportation companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability.

  • [By Joseph Griffin]

    ShipChain (CURRENCY:SHIP) traded up 14.7% against the dollar during the one day period ending at 18:00 PM Eastern on June 23rd. ShipChain has a market capitalization of $6.80 million and $5,235.00 worth of ShipChain was traded on exchanges in the last day. During the last seven days, ShipChain has traded down 8.7% against the dollar. One ShipChain token can now be bought for about $0.0373 or 0.00000598 BTC on popular exchanges including IDEX, HitBTC and Gate.io.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on SEANERGY MARITIME Common Stock (SHIP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Seanergy Maritime (NASDAQ: SHIP) and Euronav (NYSE:EURN) are both small-cap transportation companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Hot Canadian Stocks To Own For 2019

In this very special episode of MarketFoolery, host Chris Hill and analyst Matt Argersinger talk about a few of the stock market’s biggest and most mind-altering stories. Constellation Brands (NYSE:STZ), the alcoholic beverage giant behind Corona and Svedka, just bet $4 billion on Canadian cannabis producer Canopy Growth (NYSE:CGC). Constellation shares plummeted 9% on the news. What gives? With recreational marijuana laws finalizing in October, Canopy can only go up from here, right? Well, not quite.

Matt explains the risks of investing in marijuana companies, and why investors hated Constellation’s move so much. Also, Macy’s (NYSE:M) put in a pretty good quarter, but its stock still fell a whopping 13% on the report. The guys discuss how the U.S. markets are soaring while international ones have struggled year to date, as well as reports that behind the scenes, the private markets are getting frothy. They end the show with a story about Bud Light dropping fridges of free beer all over Cleveland…with a catch. Click play and find out more.

Hot Canadian Stocks To Own For 2019: Cross Timbers Royalty Trust(CRT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Cross Timbers Royalty Trust (NYSE:CRT) announced a dividend on Tuesday, August 21st, NASDAQ reports. Stockholders of record on Friday, August 31st will be paid a dividend of 0.108 per share by the oil and gas company on Monday, September 17th. The ex-dividend date of this dividend is Thursday, August 30th.

  • [By Ethan Ryder]

    News stories about Cross Timbers Royalty Trust (NYSE:CRT) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cross Timbers Royalty Trust earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned headlines about the oil and gas company an impact score of 47.0297657024049 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Hot Canadian Stocks To Own For 2019: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Logan Wallace]

    A number of hedge funds have recently bought and sold shares of ZIOP. MSD Partners L.P. increased its position in ZIOPHARM Oncology by 222.1% during the 4th quarter. MSD Partners L.P. now owns 10,986,258 shares of the biotechnology company’s stock valued at $20,544,000 after buying an additional 7,575,758 shares in the last quarter. FMR LLC bought a new position in ZIOPHARM Oncology during the 3rd quarter valued at approximately $1,647,000. Ibex Investors LLC bought a new position in ZIOPHARM Oncology during the 4th quarter valued at approximately $755,000. Bank of America Corp DE increased its position in ZIOPHARM Oncology by 198.1% during the 2nd quarter. Bank of America Corp DE now owns 99,565 shares of the biotechnology company’s stock valued at $301,000 after buying an additional 201,063 shares in the last quarter. Finally, Old West Investment Management LLC increased its position in ZIOPHARM Oncology by 784.7% during the 4th quarter. Old West Investment Management LLC now owns 223,319 shares of the biotechnology company’s stock valued at $417,000 after buying an additional 198,077 shares in the last quarter. 40.12% of the stock is owned by institutional investors.

    WARNING: “ZIOPHARM Oncology (ZIOP) Stock Price Up 8.9%” was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another site, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4199573/ziopharm-oncology-ziop-stock-price-up-8-9.html.

    ZIOPHARM Oncology Company Profile (NASDAQ:ZIOP)

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Motley Fool Transcribers]

    Ziopharm Oncology Inc  (NASDAQ:ZIOP)Q4 2018 Earnings Conference CallMarch 05, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) fell 42 percent to $2.25 in pre-market trading after dropping 31.45 percent on Thursday. Stellar Biotechnologies priced 2.075 million units at price of $2.65 per unit.
    Symantec Corporation (NASDAQ: SYMC) shares fell 25.2 percent to $21.82 in pre-market trading. Symantec reported better-than-expected earnings for its fourth quarter, but issued weak second-quarter guidance.
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares fell 9.5 percent to $10 in pre-market trading after surging 7.79 percent on Thursday.
    ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) fell 8.9 percent to $4.11 in pre-market trading after the company posted wider-than-expected Q1 loss.
    Redfin Corporation (NASDAQ: RDFN) fell 8.6 percent to $21.00 in pre-market trading after reporting Q1 results.
    Geron Corporation (NASDAQ: GERN) fell 8.3 percent to $3.33 in pre-market trading. Geron posted a Q1 loss of $0.04 per share.
    Talend S.A. (NASDAQ: TLND) shares fell 6 percent to $56 in pre-market trading after reporting Q1 results.
    Flotek Industries, Inc. (NYSE: FTK) fell 5.4 percent to $3.54 in pre-market trading after dropping 2.35 percent on Thursday.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 5.1 percent to $18.95 in pre-market trading after reporting Q1 results.
    Yelp Inc. (NYSE: YELP) shares fell 4.9 percent to $45.40 in pre-market trading. Yelp reported stronger-than-expected results for its first quarter on Thursday.
    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares fell 3.3 percent to $7.50 in pre-market trading after dropping 4.32 percent on Thursday

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now? 

Hot Canadian Stocks To Own For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Goldman Sachs Group set a €2.90 ($3.37) price target on Intesa Sanpaolo (BIT:ISP) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

  • [By Max Byerly]

    Intesa Sanpaolo (BIT:ISP) received a €3.00 ($3.53) price target from stock analysts at HSBC in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. HSBC’s target price points to a potential downside of 2.60% from the stock’s current price.

  • [By Ethan Ryder]

    Intesa Sanpaolo (BIT:ISP) has been given a €2.15 ($2.50) target price by stock analysts at UBS Group in a research note issued on Tuesday, www.boersen-zeitung.de reports. The firm presently has a “neutral” rating on the stock.

Top 10 Performing Stocks To Buy For 2019

February 22, 2019: The S&P 500 closed up 0.6% at 2,792.65. The DJIA closed up 0.7% at 26,031.30. Separately, the Nasdaq closed up 0.9% at 7,527.54.

Friday was a positive day for the broad U.S. markets. Despite seeing some major stocks take a beating in this trading session, the broad markets pulled it out and posted a gain for the day, and ultimately the week. Crude oil inched forward in the session. The S&P 500 sectors were mostly positive. The most positive sectors were technology and health care up 1.0% and 0.8%, respectively. The worst performing sectors were consumer staples and finance, down 0.7% and 0.3%, respectively.

Crude oil was last seen up 0.4% at $57.18.

Gold was last seen trading flat at $1,330.50.

The S&P 500 stock posting the largest daily percentage loss ahead of the close was The Kraft Heinz Co. (NASDAQ: KHC) which traded down about 27.5% at $34.88. The stock’s 52-week range is $34.51 to $70.01. Volume was about 134 million compared to the daily average volume of 6.6 million.

Top 10 Performing Stocks To Buy For 2019: Vuzix Corporation(VUZI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Vuzix alerts:

    VUZI LOSS NOTICE: Rosen Law Firm Reminds Vuzix Corporation Investors of Important Deadline In Class Action – VUZI (finance.yahoo.com) SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Vuzix Corporation of Class Action Lawsuit and Upcoming Deadline – VUZI (finance.yahoo.com) Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Vuzix Corporation (VUZI) (businesswire.com) Vuzix Corp (VUZI) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com) Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MEDNAX, Farmland Partners, and Vuzix and Encourages Investors to Contact the Firm (feeds.benzinga.com)

    Several brokerages have recently commented on VUZI. ValuEngine raised shares of Vuzix from a “hold” rating to a “buy” rating in a research note on Thursday, June 7th. Zacks Investment Research downgraded shares of Vuzix from a “hold” rating to a “sell” rating in a research note on Thursday, August 16th. Finally, Chardan Capital set a $10.00 price objective on shares of Vuzix and gave the company a “buy” rating in a research note on Friday, August 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $9.08.

Top 10 Performing Stocks To Buy For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Max Byerly]

    Intesa Sanpaolo (BIT:ISP) received a €3.00 ($3.53) price target from stock analysts at HSBC in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. HSBC’s target price points to a potential downside of 2.60% from the stock’s current price.

  • [By Ethan Ryder]

    Intesa Sanpaolo (BIT:ISP) has been given a €2.15 ($2.50) target price by stock analysts at UBS Group in a research note issued on Tuesday, www.boersen-zeitung.de reports. The firm presently has a “neutral” rating on the stock.

  • [By Stephan Byrd]

    Goldman Sachs Group set a €2.90 ($3.37) price target on Intesa Sanpaolo (BIT:ISP) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

  • [By Logan Wallace]

    Jefferies Financial Group set a €2.05 ($2.38) target price on Intesa Sanpaolo (BIT:ISP) in a report published on Tuesday. The brokerage currently has a neutral rating on the stock.

Top 10 Performing Stocks To Buy For 2019: Univest Corporation of Pennsylvania(UVSP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Univest Co. of Pennsylvania (UVSP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Univest Co. of Pennsylvania (NASDAQ:UVSP) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $26.35 and last traded at $26.45, with a volume of 107884 shares traded. The stock had previously closed at $26.90.

  • [By Logan Wallace]

    TRADEMARK VIOLATION NOTICE: “Univest Financial Corp (UVSP) Shares Bought by Vanguard Group Inc.” was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/4146556/univest-financial-corp-uvsp-shares-bought-by-vanguard-group-inc.html.

  • [By Stephan Byrd]

    BidaskClub upgraded shares of Univest Co. of Pennsylvania (NASDAQ:UVSP) from a strong sell rating to a sell rating in a research note released on Saturday.

Top 10 Performing Stocks To Buy For 2019: Model N, Inc.(MODN)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Model N (MODN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Model N Inc  (NYSE:MODN)Q1 2019 Earnings Conference CallFeb. 05, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Model N (MODN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Finally, there’s Model N (NYSE: MODN). My long-time readers might remember this revenue management cloud company for the life sciences and technology businesses: we sold its shares a year ago almost to the day, for a gain of 30% in about six months. I like MODN’s business, and with long-term projected growth of 44%, now might be the time to revisit the shares. If you’re a subscriber to Game-Changing Stocks, stay tuned…

  • [By Joseph Griffin]

    Model N (NYSE:MODN) and Yandex (NASDAQ:YNDX) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, analyst recommendations, dividends and profitability.

  • [By Joseph Griffin]

    Model N (NYSE: MODN) and Trade Desk (NASDAQ:TTD) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

Top 10 Performing Stocks To Buy For 2019: Pacific American Income Shares, Inc.(PAI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Project Pai (CURRENCY:PAI) traded down 6.5% against the US dollar during the 1 day period ending at 22:00 PM ET on July 11th. In the last week, Project Pai has traded flat against the US dollar. One Project Pai coin can currently be purchased for approximately $1.05 or 0.00016577 BTC on cryptocurrency exchanges including LBank, Bitfinex and Huobi. Project Pai has a total market capitalization of $0.00 and $86.99 million worth of Project Pai was traded on exchanges in the last day.

  • [By Stephan Byrd]

    PCHAIN (CURRENCY:PAI) traded down 1.2% against the dollar during the 1 day period ending at 0:00 AM E.T. on August 19th. PCHAIN has a market cap of $12.30 million and approximately $1.53 million worth of PCHAIN was traded on exchanges in the last 24 hours. Over the last week, PCHAIN has traded 9.6% lower against the dollar. One PCHAIN token can now be bought for about $0.0281 or 0.00000432 BTC on major exchanges including Bilaxy, Hotbit, DDEX and DEx.top.

  • [By Max Byerly]

    PCHAIN (CURRENCY:PAI) traded up 0.3% against the dollar during the 24 hour period ending at 0:00 AM E.T. on June 23rd. One PCHAIN token can now be bought for about $0.0807 or 0.00001322 BTC on exchanges including Bibox, IDEX and Hotbit. PCHAIN has a total market capitalization of $0.00 and $2.46 million worth of PCHAIN was traded on exchanges in the last 24 hours. During the last week, PCHAIN has traded 18.4% lower against the dollar.

  • [By Joseph Griffin]

    Here’s how similar cryptocurrencies have performed during the last 24 hours:

    Get PCHAIN alerts:

    Maker (MKR) traded down 2.8% against the dollar and now trades at $662.44 or 0.16972011 BTC. IOStoken (IOST) traded down 0.3% against the dollar and now trades at $0.0396 or 0.00000526 BTC. THETA (THETA) traded down 2.8% against the dollar and now trades at $0.13 or 0.00003297 BTC. Aurora (AOA) traded up 28.2% against the dollar and now trades at $0.0164 or 0.00000420 BTC. Pundi X (NPXS) traded down 3.5% against the dollar and now trades at $0.0006 or 0.00000016 BTC. IOST (IOST) traded down 3.4% against the dollar and now trades at $0.0078 or 0.00000200 BTC. Huobi Token (HT) traded 6.2% lower against the dollar and now trades at $1.79 or 0.00045840 BTC. Project Pai (PAI) traded up 69.2% against the dollar and now trades at $0.0608 or 0.00001557 BTC. MCO (MCO) traded 2.8% higher against the dollar and now trades at $4.39 or 0.00068464 BTC. Oyster (PRL) traded flat against the dollar and now trades at $0.51 or 0.00008001 BTC.

    PCHAIN Token Profile

Top 10 Performing Stocks To Buy For 2019: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Money Morning News Team]

    However, VivoPower and our other penny stocks to watch this week already saw big gains. After looking at our 10 top penny stocks to watch, we’ll show you a small-cap stock with serious profit potential in its future…

    Penny Stock Current Share Price Law Week’s Gain
    VivoPower International Plc. (Nasdaq: VVPR) $3.05 88.57%
    Euro Tech Holdings Co. (Nasdaq: CLWT) $3.77 75.11%
    Boxlight Corp. (Nasdaq: BOXL) $6.36 65.38%
    Chine Recycling Energy Corp. (Nasdaq: CREG) $2.01 45.92%
    Vivis Inc. (Nasdaq: VVUS) $0.52 38.82%
    HC2 Holdings Inc. (NYSE: HCHC) $6.79 33.49%
    Biostar Pharmaceuticals Inc. (Nasdaq: BSPM) $2.67 32.23%
    Turtle Beach Corp. (Nasdaq: HEAR) $6.99 30.19%
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $3.30 29.24%
    Rexahn Pharmaceuticals Inc. (NYSE: RNN) $2.11 29.19%

    While the gains of last week’s top penny stocks are exciting, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
     Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Buy For 2019: Curtiss-Wright Corporation(CW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Curtiss-Wright (CW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Curtiss-Wright Corp  (NYSE:CW)Q4 2018 Earnings Conference CallFeb. 27, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Curtiss-Wright (CW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Dynamic Technology Lab Private Ltd raised its holdings in Curtiss-Wright Corp. (NYSE:CW) by 86.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,948 shares of the aerospace company’s stock after buying an additional 2,760 shares during the period. Dynamic Technology Lab Private Ltd’s holdings in Curtiss-Wright were worth $708,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Public Employees Retirement System of Ohio grew its stake in Curtiss-Wright Corp. (NYSE:CW) by 84.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,994 shares of the aerospace company’s stock after purchasing an additional 17,810 shares during the quarter. Public Employees Retirement System of Ohio owned about 0.09% of Curtiss-Wright worth $4,641,000 at the end of the most recent quarter.

Top 10 Performing Stocks To Buy For 2019: Zillow Group, Inc.(Z)

Advisors’ Opinion:

  • [By Steve Symington, Anders Bylund, and Rich Duprey]

    We asked three top Motley Fool investors to weigh in to that end. Here’s why they like Under Armour (NYSE:UA)(NYSE:UAA), Helios & Matheson (NASDAQ:HMNY), and Zillow Group (NASDAQ:Z)(NASDAQ:ZG).

  • [By Anders Bylund, Jeremy Bowman, and Rich Duprey]

    Like its peer Zillow (NASDAQ:Z) (NASDAQ:ZG), Redfin is disrupting the real-estate market with online listings, but Redfin operates differently from Zillow. While Zillow relies on advertising from real-estate agents to drive its business, Redfin seeks to circumvent the traditional real-estate model by selling properties through its own agents and making the experience customer-centric by lowering commissions, incentivizing customer service, and using technology to make the search for a new home better and easier.  

  • [By Ethan Ryder]

    Zillow (NASDAQ:Z) CMO Jeremy Wacksman sold 47,788 shares of the firm’s stock in a transaction on Thursday, May 10th. The stock was sold at an average price of $55.64, for a total value of $2,658,924.32. Following the completion of the transaction, the chief marketing officer now owns 48,489 shares in the company, valued at $2,697,927.96. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

  • [By Chris Hill]

    Hill: Zillow’s (NASDAQ:Z) (NASDAQ:ZG) second quarter revenue came in lower than expected. Shares of the real estate website operator down 14% this week. Jason, it was not just the weak revenue that Wall Street didn’t like.

Top 10 Performing Stocks To Buy For 2019: J.B. Hunt Transport Services Inc.(JBHT)

Advisors’ Opinion:

  • [By Jim Crumly]

    As for individual stocks, Arconic (NYSE:ARNC) moved up on a buyout rumor and some positive business updates, and J.B. Hunt Transport Services (NASDAQ:JBHT) announced a big jump in profit.

  • [By Joseph Griffin]

    J B Hunt Transport Services (NASDAQ:JBHT) released its quarterly earnings data on Monday. The transportation company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.28 by $0.09, Bloomberg Earnings reports. The company had revenue of $2.14 billion for the quarter, compared to analyst estimates of $2.05 billion. J B Hunt Transport Services had a return on equity of 26.63% and a net margin of 9.54%. The firm’s revenue was up 23.9% compared to the same quarter last year. During the same period last year, the company posted $0.88 earnings per share.

  • [By Garrett Baldwin]

    The ongoing trade rift between the United States and China continues to plague international markets. Despite reports that both countries are working behind the scenes to prevent additional detrimental trade policies, both countries recently proposed tens of billions in new tariffs on one another. The United States has accused China of widespread intellectual property theft, while China has accused the United States of unfair trade practices, including price manipulation in the agricultural industry. This morning, it’s worth noting that proposed tariffs on U.S. business jets will likely not provide a competitive advantage to foreign competition. Reuters reports that Chinese aviation executives do not see the layer of protectionism as a way to bolster the nation’s local market. Check back to Money Morning today for more insight on how the ongoing trade war could affect your investments.
    Finally, investors will continue to monitor ongoing developments in Washington around the presidency of Donald Trump. The White House has asked a federal judge to block prosecutors from reviewing any files seized from his lawyer’s office during a raid by the FBI last week. The agency seized a trove of documents from lawyer Michael Cohen’s office as part of an investigation into a payment of hush money. The spat between the White House and the FBI continues a day after former FBI Director James Comey called Trump “morally unfit to be president.”
    Three Stocks to Watch Today: BAC, NFLX, AAPL
    Shares of Bank of America Corp. (NYSE: BAC) added nearly 1% after the nation’s largest bank by deposits topped Wall Street earning expectations. The financial institution leads a busy day of earnings reports on Wall Street and hopes to keep its positive momentum from previous quarters. The firm reported earnings per share of $0.62 on top of $23.27 billion in revenue. That topped expectations of $0.59 on top of $22.91 billion thanks to strong growth in its consumer loan business and the r

  • [By ]

    In the Lightning Round, Cramer was bullish on T-Mobile US (TMUS) , Lennar (LEN) , Toll Brothers (TOL) , Tyson Foods (TSN) , JB Hunt Transport Services (JBHT) and International Paper (IP) .

  • [By Stephan Byrd]

    Rhumbline Advisers grew its position in shares of J B Hunt Transport Services Inc (NASDAQ:JBHT) by 7.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 194,057 shares of the transportation company’s stock after purchasing an additional 13,292 shares during the period. Rhumbline Advisers owned 0.18% of J B Hunt Transport Services worth $23,588,000 at the end of the most recent quarter.

Top 10 Performing Stocks To Buy For 2019: Ampio Pharmaceutical(AMPE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 10,472,904 shares, a drop of 6.6% from the May 15th total of 11,209,042 shares. Based on an average daily trading volume, of 806,646 shares, the days-to-cover ratio is currently 13.0 days. Currently, 13.5% of the shares of the company are sold short.

  • [By Maxx Chatsko]

    Shares of Ampio Pharmaceuticals (NYSEMKT:AMPE) were devastated today, dropping 71% in the first hour of trading, after the company delivered a regulatory update in a Securities and Exchange Commission filing concerning its lead drug candidate Ampion. The drug, which is being developed as a treatment for severe osteoarthritis of the knee, appeared to report positive results in a phase 3 trial at the end of 2017. But investors just learned that the data collected will not be sufficient to support regulatory approval. 

  • [By Shane Hupp]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a significant increase in short interest in the month of June. As of June 29th, there was short interest totalling 14,752,101 shares, an increase of 39.8% from the June 15th total of 10,555,723 shares. Currently, 19.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,744,324 shares, the short-interest ratio is currently 8.5 days.

Top 5 Stocks To Buy For 2019

Media coverage about Pareteum (NASDAQ:TEUM) has been trending somewhat positive this week, Accern reports. The research group scores the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Pareteum earned a coverage optimism score of 0.18 on Accern’s scale. Accern also gave headlines about the company an impact score of 47.7443114638008 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Shares of NASDAQ:TEUM traded down $0.08 during trading on Thursday, reaching $2.78. The company had a trading volume of 1,937,500 shares, compared to its average volume of 2,353,299. Pareteum has a 12 month low of $0.54 and a 12 month high of $3.59.

Top 5 Stocks To Buy For 2019: MercadoLibre Inc.(MELI)

Advisors’ Opinion:

  • [By Danny Vena]

    MercadoLibre, Inc. (NASDAQ:MELI) had a banner year in 2017, and things were looking up to start off 2018. When the company released its fourth-quarter financial results in February, it reported revenue of $437 million, up 70% year over year in U.S. dollars and almost doubling in local-currency terms. It also announced that it would be deconsolidating the results of its Venezuelan subsidiary, which had long been a drag on its financials due to persistent currency devaluations and spiraling hyperinflation. After doubling last year, MercadoLibre’s stock had gained over 30% again by early March.

  • [By Danny Vena]

    For investors in MercadoLibre (NASDAQ:MELI), the leading e-commerce platform in Latin America, it was difficult to decipher the results for its just completed first quarter. The company’s reported net revenue of $321 million, an increase of just 19% year over year, was below analysts’ expectations and significantly lower than the stellar growth rates investors have come to expect. Bottom-line results were even worse, with a loss per share of $0.29, compared to gain of $1.10 in the prior-year quarter.

  • [By Danny Vena]

    Until recently, it seemed MercadoLibre (NASDAQ:MELI) could do no wrong. The company was reporting enviable financial and operational metrics, and the stock was hitting all-time highs. Then, something happened on the way to the online sale.

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Mercadolibre alerts:

    Insider Buying: Mercadolibre Inc (MELI) Director Acquires 1,708 Shares of Stock (americanbankingnews.com) MercadoLibre’s Recent Financials Mask Operational Growth (seekingalpha.com) Mercadolibre Inc (MELI) Receives Consensus Recommendation of “Hold” from Analysts (americanbankingnews.com) If Its Growth Is So Fabulous, Why Is MercadoLibre Stock Falling? (fool.com) The “Amazon” of Latin America (fool.com)

    Shares of Mercadolibre stock traded down $0.23 on Friday, reaching $314.70. The stock had a trading volume of 1,539,558 shares, compared to its average volume of 725,705. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.25. Mercadolibre has a 1 year low of $217.06 and a 1 year high of $417.91. The company has a market cap of $13.46 billion, a P/E ratio of 124.39 and a beta of 2.08.

  • [By Motley Fool Staff]

    As this episode drops, we are three years into that very first sampler, which he dubbed simply “Five Stocks for the Next Five Years.” The picks were Activision Blizzard (NASDAQ:ATVI), Casey’s General Stores (NASDAQ:CASY), FireEye (NASDAQ:FEYE), MercadoLibre (NASDAQ:MELI), and Middleby (NASDAQ:MIDD) — and we’ll tell you up front that at this stage, David’s far from batting a thousand on the set.

Top 5 Stocks To Buy For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Jefferies Financial Group set a €2.05 ($2.38) target price on Intesa Sanpaolo (BIT:ISP) in a report published on Tuesday. The brokerage currently has a neutral rating on the stock.

  • [By Stephan Byrd]

    Goldman Sachs Group set a €2.90 ($3.37) price target on Intesa Sanpaolo (BIT:ISP) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

  • [By Max Byerly]

    Intesa Sanpaolo (BIT:ISP) received a €3.00 ($3.53) price target from stock analysts at HSBC in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. HSBC’s target price points to a potential downside of 2.60% from the stock’s current price.

  • [By Stephan Byrd]

    Intesa Sanpaolo (BIT:ISP) received a €2.90 ($3.37) price target from research analysts at Deutsche Bank in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the stock.

Top 5 Stocks To Buy For 2019: TD Ameritrade Holding Corporation(AMTD)

Advisors’ Opinion:

  • [By Logan Wallace]

    TD Ameritrade (NASDAQ:AMTD) announced a quarterly dividend on Monday, April 23rd, RTT News reports. Shareholders of record on Tuesday, May 8th will be paid a dividend of 0.21 per share by the financial services provider on Tuesday, May 22nd. This represents a $0.84 annualized dividend and a yield of 1.42%. The ex-dividend date is Monday, May 7th.

  • [By Jordan Wathen]

    The discount broker now has its sights set on a larger demographic of investors who use exchange-traded funds (ETFs) to invest. Firstrade rolled out commission-free trades on more than 700 ETFs, including some popular ETFs from issuers like Vanguard, which are hard to find in fee-free form after they were culled from TD Ameritrade’s (NASDAQ:AMTD) list of commission-free ETFs last year.

  • [By ]

    Darn hard to not like the numbers out of Action Alerts PLUS holding JPMorgan & Chase (JPM) . Profits up nicely in all segments vs. the fourth quarter. Big year-over-year spikes in return on assets and equity from a year ago. Trading revenue up thanks to the return of volatility in the first quarter (can’t wait to see the blowout quarters from TD Ameritrade (AMTD) and Schwab (SCHW) ). Good card revenue growth from the fourth-quarter bodes well for retailer’s first-quarter results.

Top 5 Stocks To Buy For 2019: Applied Genetic Technologies Corporation(AGTC)

Advisors’ Opinion:

  • [By ]

    1. Applied Genetic Technologies (Nasdaq: AGTC)
    Over the last week, this stock just exploded higher with massive upside momentum. Hitting resistance at $7.00 per share, my play on this one is to enter longs on a break out above $7.00 per share.

  • [By Stephan Byrd]

    News headlines about Applied Genetic Technologies (NASDAQ:AGTC) have been trending somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Applied Genetic Technologies earned a daily sentiment score of 0.07 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 46.4149815454551 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Ethan Ryder]

    News articles about Applied Genetic Technologies (NASDAQ:AGTC) have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Applied Genetic Technologies earned a news impact score of 0.20 on Accern’s scale. Accern also assigned media headlines about the biotechnology company an impact score of 45.8761095143233 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 5 Stocks To Buy For 2019: Aerojet Rocketdyne Holdings, Inc. (AJRD)

Advisors’ Opinion:

  • [By Rich Smith]

    Aerojet Rocketdyne (NYSE:AJRD) stock lost 12% of its value in the two days after the company reported earnings  for the first quarter of 2018 — a miss, and its third such miss in a row, according to data from Yahoo! Finance . Since that report and subsequent drop, however, Aerojet Rocketdyne has come roaring back, recovering all of its losses, and even adding a bit more.

  • [By Rich Smith]

    On the one hand, faced with the prospect of American companies inventing a new rocket engine to power United Launch Alliance (ULA) Atlas V rockets, Russia’s space agency has thrown shade on America’s space industry. American engines are overpriced, says Mr. Komarov. And they’re of worse quality than rocket engines made in Russia — the implication being that ULA should buy Russian RD-180 engines instead of new engines from Blue Origin or Aerojet Rocketdyne (NYSE:AJRD).

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Aerojet Rocketdyne (AJRD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Rich Smith]

    In fact, Boeing and Lockheed Martin look to be two-time winners, as the second largest bump in funding is going to help pay for deep space missions, and to NASA’s Orion crew vehicle and Space Launch System (SLS), which are designed to carry them. Orbital ATK (soon to be absorbed into Northrop Grumman) and Aerojet Rocketdyne (NYSE:AJRD) are other key players on the SLS project. Congress wants to pour an additional $294 million into this program, funding it with $5.1 billion next year.

  • [By Rich Smith]

    One logical choice to build this replacement engine was engine-maker Aerojet Rocketdyne (NYSE:AJRD), which builds the engines for ULA’s larger Delta IV rockets. But in an effort to cut costs, ULA also invited Blue Origin to bid on the project, introducing some price competition and innovative thinking into the engine competition.

Hot Performing Stocks To Own For 2019

L Brands (LB) soared to the top of the S&P 500 today after the parent company of Victoria’s Secret reported a 10% drop in same-store sales.

Agence France-Presse/Getty Images

L Brands surged 11% to $47.85 today, while the S&P 500 rose 0.2% to 2,357.49. And while L Brands was the best performer, retailers made up half of the 10 best performing stocks in the benchmark today: Nordstrom (JWN) advanced 2.9% to $44.71, Gap (GPS) jumped 5.1% to $24.06, Kohl’s (KSS) climbed 5.6% to $39.60, and Bed Bath & Beyond (BBBY), which reported earnings last night, gained 3.4% to $39.08.

RBC analysts Brian Tunick and Kate Fitzsimons attributed L Brand’s big move to a short squeeze. They explain:

Bottom line, with the stock recently hitting a 52 week low yesterday, the 10% squeeze we’re seeing in the shares is likely reflective of the “better-than-feared” trade rather than long-only buyers stepping in. The reality is that LB’s fundamentals are still challenged (down 10% comps are nothing to throw a party for), with the overhang on LB shares related to how much of the damage is self-inflicted (7% category exit headwind called out this month) vs. a tough mall traffic environment. Net/net, we remain neutral on LB shares given the lack of top line visibility as LB executes these category exits, with April and 2Q17’s merch margin commentary ones to watch for signals that we’ve rounded the bottom.

Hot Performing Stocks To Own For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Max Byerly]

    Intesa Sanpaolo (BIT:ISP) received a €3.00 ($3.53) price target from stock analysts at HSBC in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. HSBC’s target price points to a potential downside of 2.60% from the stock’s current price.

  • [By Stephan Byrd]

    Goldman Sachs Group set a €2.90 ($3.37) price target on Intesa Sanpaolo (BIT:ISP) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

Hot Performing Stocks To Own For 2019: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights, Chuck Saletta, and Brian Feroldi]

    That’s the question we presented to three Motley Fool contributors. They identified Ligand Pharmaceuticals (NASDAQ:LGND), Portola Pharmaceuticals (NASDAQ:PTLA), and Supernus Pharmaceuticals (NASDAQ:SUPN) as top biotech stocks to buy in September. Here’s why these biotechs stood out:

  • [By Keith Speights]

    Which companies that are relatively small right now could become the big biotechs of the future? Here’s why I think that Editas Medicine (NASDAQ:EDIT), Ligand Pharmaceuticals (NASDAQ:LGND), and Exelixis (NASDAQ:EXEL) could be monster biotech stocks in the making.

  • [By Shane Hupp]

    Ligand Pharmaceuticals Inc. (NASDAQ:LGND) Director Todd C. Davis sold 9,000 shares of Ligand Pharmaceuticals stock in a transaction on Friday, August 17th. The shares were sold at an average price of $239.78, for a total transaction of $2,158,020.00. Following the transaction, the director now owns 44,806 shares in the company, valued at approximately $10,743,582.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Performing Stocks To Own For 2019: MoSys, Inc.(MOSY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MoSys (MOSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 27 percent to $1.9265 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…